FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA takes first step in possible reversal of ban on some peptides The Washington Post In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for RFK Jr. and the Perils of Peptides Washington Monthly